August 24, 2017 / 6:49 AM / 3 months ago

BRIEF-Karo Pharma Q2 EBITDA jumps to SEK 49.7 mln

Aug 24 (Reuters) - KARO PHARMA AB

* Q2 NET SALES SEK 142.5 MILLION VERSUS SEK 81.9 MILLION YEAR AGO

* Q2 EARNINGS BEFORE DEPRECIATION (EBITDA) SEK 49.7 MILLION VERSUS SEK 3.3 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below